[Pharm-policy] BMS product sales: 1997 to 1999

[James Love]

http://www.sec.gov/Archives/edgar/data/14272/0000014272-00-000002-index.html


DESCRIPTION OF SEGMENTS
-----------------------

MEDICINES:

----------

This segment includes sales of pharmaceuticals and consumer medicines.
Sales of selected products and product categories are as follows:

                                          1999      1998     1997
                                        ------    ------   ------
 PRAVACHOL*                             $1,704    $1,643   $1.437
 TAXOL*                                  1,481     1,206      941
 GLUCOPHAGE                              1,317       862      579
 Oncology Therapeutics Network             894       657      480
 BUSPAR*                                   605       531      443
 ZERIT*                                    605       551      398
 PARAPLATIN*                               600       525      437
 PLAVIX                                    547       144        -
 CAPOTEN*/CAPOZIDE*                        484       636      795
 MONOPRIL*                                 424       380      328
 CEFZIL*                                   402       358      318
 SERZONE*                                  332       257      185
 AVAPRO                                    255       123       28
 EXCEDRIN*                                 240       241      206
 VIDEX*                                    205       162      152

=======================================================
James Love, Director           | http://www.cptech.org
Consumer Project on Technology | mailto:love@cptech.org 
P.O. Box 19367                 | voice: 1.202.387.8030
Washington, DC 20036           | fax:   1.202.234.5176
=======================================================